Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer

Development of aromatase inhibitor resistant breast cancer among postmenopausal women continues to be a major clinical obstacle. Previously, our group demonstrated that as breast cancer cells transition from hormone-dependent to hormone-independent, they are associated with increased growth factor s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallegos, Karen M., Patel, Jankiben R., Llopis, Shawn D., Walker, Rashidra R., Davidson, A. Michael, Zhang, Wensheng, Zhang, Kun, Tilghman, Syreeta L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951058/
https://www.ncbi.nlm.nih.gov/pubmed/33718123
http://dx.doi.org/10.3389/fonc.2021.540134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951058/
https://www.ncbi.nlm.nih.gov/pubmed/33718123
http://dx.doi.org/10.3389/fonc.2021.540134

Ejemplares similares